LMNX Related Analyst Ratings
-
William Blair Initiates Coverage on Luminex (LMNX) with a Market Perform
-
Northland Securities Initiates Coverage on Luminex (LMNX) with an Outperform
-
First Analysis Upgrades Luminex (LMNX) to Overweight
-
Piper Jaffray Initiates Coverage on Luminex (LMNX) with a Neutral
-
UBS Initiates Coverage on Luminex (LMNX) with a Neutral
-
Cowen & Co Initiates Coverage on Luminex (LMNX) with a Neutral; Upside Potential, But Reflected In Premium Valuation
-
Matrix USA Rating Changes 10/08
-
Thomas Weisel Downgrades Luminex (LMNX) to Market Weight
-
JPMorgan Starts Luminex (LMNX) at Neutral
-
Jesup & Lamont Downgrades Luminex (LMNX) to Neutral
-
Matrix USA Rating Changes 1/18
-
Matrix USA Research Rating Changes: 09/26
-
Canaccord Adams Initiates Coverage on Luminex (LMNX) with a Buy
-
Thomas Weisel Starts Luminex (LMNX) at Overweight
-
Soleil Securities upgrades Luminex (LMNX) to Buy
-
Soleil Securities downgrades Luminex (LMNX) to Hold
-
House and Senate Negotiators agreed on $2.3B Avian Flu Funding - Analyst
-
Brean Murray Starts LMNX at Buy
Back to LMNX Stock Lookup
